Michelle Werner

Michelle Werner

Director/Board Member at OMEGA THERAPEUTICS, INC.

Net worth: - $ as of 29/04/2024

Health Technology
Consumer Services
Health Services

Profile

Michelle C.
Werner
is currently the CEO-Partner at Flagship Pioneering, the Chief Executive Officer at Alltrna, and the Director at Omega Therapeutics, Inc. She previously worked as a Director at Channel One, Inc., the US Brand Lead for Reyataz at Bristol Myers Squibb Co. from 2014 to 2015, and as the VP & Head-Global Haematology Franchise at AstraZeneca PLC in 2020.
Ms. Werner received her undergraduate degree from the University of Pennsylvania in 1997 and her MBA from the London Business School in 2005.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/08/2023 0 ( -.--% ) - $ 29/04/2024

Michelle Werner active positions

CompaniesPositionStart
OMEGA THERAPEUTICS, INC. Director/Board Member 27/08/2023
Private Equity Investor 31/03/2022
Chief Executive Officer 31/03/2022
All active positions of Michelle Werner

Former positions of Michelle Werner

CompaniesPositionEnd
ASTRAZENECA PLC Corporate Officer/Principal 01/07/2020
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/05/2015
Director/Board Member -
See the detail of Michelle Werner's experience

Training of Michelle Werner

London Business School Masters Business Admin
University of Pennsylvania Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michelle Werner's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ASTRAZENECA PLC

Health Technology

BRISTOL-MYERS SQUIBB COMPANY

Health Technology

OMEGA THERAPEUTICS, INC.

Health Technology

Private companies3

Health Services

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Michelle Werner